ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (year values) |
|||||||
2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 34.2% | 37.9% | 38.2% | 41.6% | ||
Changes by years, y/y, % | +4pp | +0pp | +5.7% |
ОЗОН Фармацевтика. EBITDA margin, %
ОЗОН Фармацевтика. EBITDA margin, changes, pp
ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (quarter values) |
||||||||
2021Q4 | 2022Q4 | 2023Q2 | 2023Q4 | 2024Q2 | LTM ? | |||
EBITDA margin, % | ? | 30.4% | 43.2% | 40.1% | 41.6% | |||
Changes by years, y/y, % | +10pp | |||||||
Changes by quarters, q/q, % | +13pp | -3pp |